Phosphorylation Mechanism of Phosphomevalonate Kinase: Implications for Rational Engineering of Isoprenoid Biosynthetic Pathway Enzymes by Huang, Meilan et al.
Phosphorylation Mechanism of Phosphomevalonate Kinase:
Implications for Rational Engineering of Isoprenoid Biosynthetic
Pathway Enzymes
Huang, M., Wei, K., Li, X., McClory, J., Hu, G., Zou, J-W., & Timson, D. J. (2016). Phosphorylation Mechanism
of Phosphomevalonate Kinase: Implications for Rational Engineering of Isoprenoid Biosynthetic Pathway
Enzymes. Journal of Physical Chemistry B. DOI: 10.1021/acs.jpcb.6b08480
Published in:
Journal of Physical Chemistry B
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2016 American Chemical Society
This document is the Accepted Manuscript version of a Published Work that appeared in final form in
Journal of Physical Chemistry B, copyright © American Chemical Society after peer review and technical editing by the publisher.
To access the final edited and published work see http://pubs.acs.org/doi/abs/10.1021/acs.jpcb.6b08480
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:06. Nov. 2017
1 
 
Phosphorylation Mechanism of Phosphomevalonate Kinase: Implications 
for Rational Engineering of Isoprenoid Biosynthetic Pathway Enzymes 
 
Meilan Huang, *,† Kexin Wei, † Xiao Li, † James McClory, † Guixiang Hu, ‡ Jian-Wei Zou, ‡ 
David Timson ξ  
 
†School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir 
Building, Stranmillis Road, Belfast, BT9 5AG, Northern Ireland, United Kingdom 
‡School of Biotechnology and Chemical Engineering, Ningbo Institute of Technology, 
Zhejiang University, Ningbo 315100, China 
ξ School of Pharmacy and Biomolecular Sciences, The University of Brighton, Huxley 
Building. Lewes Road, Brighton, BN2 4GJ, United Kingdom 
 
Corresponding author  
*Meilan Huang 
Phone: +44 28 9097 4698.  
Fax: +44 28 9097 6524. 
E-mail: m.huang@qub.ac.uk. 
 
 
 
 
 
 
 
 
 
2 
 
Abstract  
Mevalonate pathway is of important clinical, pharmaceutical and biotechnological relevance. 
However, lack of the understanding of the phosphorylation mechanism of the kinases in this 
pathway has limited rationally engineering the kinases in industry. Here the phosphorylation 
reaction mechanism of a representative kinase in the mevalonate pathway, 
phosphomevalonate kinase, was studied by using molecular dynamics and hybrid QM/MM 
methods. We find that a conserved residue (Ser106) is reorientated to anchor ATP via a stable 
H-bond interaction. In addition, Ser213 located on the α-helix at the catalytic site is 
repositioned to further approach the substrate, facilitating the proton transfer during the 
phosphorylation. Furthermore, we elucidate that Lys101 functions to neutralize the negative 
charge developed at the β-, γ-bridging oxygen atom of ATP during phosphoryl transfer. We 
demonstrate that the dissociative catalytic reaction occurs via a direct phosphorylation 
pathway. This is the first study on the phosphorylation mechanism of a mevalonate pathway 
kinase. The elucidation of the catalytic mechanism not only sheds light on the common 
catalytic mechanism of GHMP kinase superfamily, but also provides the structural basis for 
engineering the mevalonate pathway kinases to further exploit their applications in the 
production of a wide range of fine chemicals such as biofuels or pharmaceuticals.  
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1. Introduction 
The GHMP kinase superfamily is named after Galactokinase (GALK), Homoserine kinase 
(HK), Mevalonate kinase (MK) and Phosphomevalonate kinase (PMK). 1 The superfamily, 
now including over 800 protein sequences, is defined by three conserved sequence motifs (I-
III). Despite the conserved sequence, the structures of GHMP kinases show some differences 
with diverse Mg coordination environments and a range of substrates acting as the γ-
phosphate acceptor during the phosphorylation reaction. Based on the structural features of 
the active sites of GHMP kinases, two catalytic mechanisms have been proposed. The first 
mechanism is a common catalytic mechanism where a negatively charged residue (aspartate) 
acts as a catalytic base, assisting proton abstraction from the hydroxyl group of the substrate. 
As a result, a more strongly nucleophilic alkoxide ion is formed, which in turn attacks the γ-
phosphate of ATP. Meanwhile, a positively charged residue such as lysine or arginine is often 
observed in the active site. These are postulated to stabilise the negative charges developed 
during phosphorylation. 2 The catalytic base mechanism was suggested for MK, GALK and 
diphosphomevalonate decarboxylase (DPM-DC) based on site-directed mutagenesis studies. 
3-7 The second mechanism was proposed for homoserine kinase (HK), where asparagine and 
threonine residues replace the aspartate and lysine respectively. Since there is no potential 
catalytic base present, the hydroxyl group of the substrate was proposed to directly attack the 
γ-phosphate of ATP assisted by enzyme-mediated stabilisation of the transition state. 8,9 
Recently, a combined QM/MM calculation was used to investigate the reaction mechanism of 
human GALK. 10 It was found that the reaction occurs via direct a phosphorylation 
mechanism instead of a base catalyzed mechanism. However, whether the direct 
phosphorylation mechanism is common for all GHMP kinases is still yet to be determined.  
GHMP kinase family participates in several essential metabolic pathways, among which the 
mevalonate (MVA) pathway is of important clinical, pharmaceutical and biotechnological 
relevance. 11 The MVA pathway is composed of three GHMP kinases, MK, PMK and 
diphosphomevalonate decarboxylase (DPM-DC). 12 The product of the MVA pathway, 
isopentenyl diphosphate (IPP), is the building block of isoprenoids, the largest class of 
natural products and comprising an extremely diverse range of chemical structures. Due to 
the ubiquity and metabolic significance of isoprenoids, it is not surprising that excess or 
deficiency in the isoprenoid synthesis can cause cellular dysfunction and various diseases.  
e.g. The MVA pathway is essential for the survival of Streptococcus pneumonia in the lung 
and serum. 13 It was reported that the product of PMK, diphosphomevalonate (DPM), feed-
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back inhibits MK in S. pneumonia. Therefore, regulation of the MVA pathway would provide 
novel therapies to intervene in the pathway to inhibit the devastating effect of the organism. 
Recently, inhibitors of GHMP kinases in the mevalonate pathway of S. pneumoniae were 
reported. 14-16 
Isoprenoids have been recognized as anticancer and antimalarial drugs17,18 as well as potential 
gasoline replacements. 19,20 Chemical synthesis or modification of isoprenoids is difficult due 
to their structural complexity, and therefore the large scale of production of isoprenoids in 
industry is hindered. Metabolic engineering of the MVA pathway provides an alternative 
approach to traditional synthesis of these natural products. 21 A number of metabolic 
engineering studies have been reported to optimize the enzymes in this pathway to improve 
the yields of isoprenoids in Escherichia coli. 22-27 
Elucidation of the catalytic mechanism of the kinases involved in MVA pathway can help to 
reveal the common features in the catalytic mechanisms shared by GHMP superfamily 
kinases, which would shed light on the development of antibiotic therapies that target the 
bacterial enzymes involved in the MVA pathway. It may also provide guidance for rationally 
engineering the kinases for industrial applications such as the more efficient production of 
isoprenoid-based biofuels.  PMK, a representative kinase in the MVA pathway, is a special 
GHMP kinase that has a negatively charged phosphate as the acceptor of the phosphorylation. 
Different from most GHMP kinases where Mg2+ is coordinated to more than one phosphoryal 
groups of ATP, the magnesium ion in PMK is coordinated to both the γ-phosphate of ATP 
and the phosphoryal group of the substrate. In the present research, the reaction mechanism 
of PMK was investigated by molecular dynamics (MD) simulations and hybrid QM/MM 
calculations.  
 
2. Methods  
2.1 Protein Preparation 
The crystal structure of PMK from S. pneumoniae in complex with its substrate (R)-5- 
phosphomevalonate (PMV) and AMPPNP·Mg2+ (PDB code: 3GON) was used as the initial 
structure. 28   The nitrogen atom bridging the β- and γ- phosphate groups in AMPPNP was 
substituted with an oxygen atom, yielding an ATP molecule. Three structural water 
molecules coordinated to the magnesium ion were kept in the structure.  
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2.2 Molecular Dynamics Simulations 
The parameters of PMV were prepared by single point charge calculation using Gaussian 09 
29 at the level of HF/6-31G (d). Then RESP charges were generated using antechamber 30 
encoded in Amber 10. 31 The partial atomic charges of PMV and ATP were calculated 
separately, while atom type and charge of magnesium ion was directly utilized from Amber 
Parm99 force field. 32  
A TIP3P water box was added in the protein system with the minimum distance between the 
box wall and protein of 8 Å. A total of 8,563 water molecules were added. In addition, 13 
sodium ions were added to maintain the neutrality of the system. The solvate including the 
protein, ATP and the substrate PMV were restrained with a force constant 0.5 kcal·mol-1·Å-2, 
while water molecules were set free in order to remove abnormal van der Waals forces 
between the protein and surrounding water molecules. In total 5,000 steps of constrained 
minimization were performed comprised of 2,500 steps steepest descent minimization 
followed by 2,500 steps conjugate gradient minimization.  
MD simulations were performed for the wild-type (WT) kinase and five variants, K9R, K9M, 
K101R, K101M and A293T respectively. After minimisation, the protein system was heated 
slowly from 0 K to 300 K with a time step of 1 fs over 500 ps. A periodic boundary condition 
was applied, and equilibration was carried out with NVT ensemble at 300 K for another 500 
ps. The Particle Mesh Ewald method was used to calculate the long-range electrostatic 
interactions with the non-bonded van der Waals force being set to 10 Å. 33 The SHAKE 
method was used to constrain covalent bonds involving hydrogen atoms. 34 A molecular 
dynamics (MD) simulation (10 ns) was run for the wild-type (WT) enzyme and each of the 
variant systems with a time step of 1 fs using NPT ensemble under a reference pressure of 1 
atm and temperature of 300 K. Clustering analysis was performed for the last nanosecond 
trajectory of MD simulation to obtain the representative conformation of the kinase. 35  
 
2.3 QM/MM calculations  
The protein complexes were optimized using the two-layer QM/MM method implemented in 
ONIOM. The energy is calculated by Eq. 1: 
 
mod mod
ONIOM high low medium
real el real elE E E E= + −                 (Eq. 1) 
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The high layer was treated with a quantum mechanics (QM) method and the low layer was 
treated with a molecular mechanics (MM) method. The entire molecule was denoted as the 
real system. The boundary between QM and MM region was treated using hydrogen atoms as 
link atoms. The density functional theory with the B3LYP-D method and 6-31G(d) basis set 
was used to calculate the QM region. The rest of the system was treated using AMBER 
Parm99 force field. 32 
The electrostatic interaction between the QM and MM regions were optimized by using 
electronic embedding, which incorporates the partial charges of the MM region into the 
quantum mechanical Hamiltonian and allows the QM wavefunction to be polarised. 36 Merz-
Kollman-Singh approximate charge was used during optimization microiterations with 
electronic embedding. 37,38 
The QM region included ATP, PMV, Ala293, Asp297, Lys9, Lys101, Ser213 and three water 
molecules that were coordinated to the Mg ion (Figure 1). ATP was truncated to keep the 
triphosphate arm. There were 83 atoms in total in the QM region and the total charge of the 
QM system was -3. Only the side chains of the residues in the QM region were retained to 
compromise between the time-consuming nature of the electronic embedding scheme and the 
accuracy of the calculation. 39 A reduced system within 12 Å of the active site was subjected 
to a preliminary minimization, while the residues within 6 Å of the active site were allowed 
to move and the rest of the system was kept frozen. 
 
 
Figure 1. The QM region (highlighted in red cycle) of PMK in the QM/MM calculation 
 
3. Results and Discussion 
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3.1 Identification of key residues in the catalytic reaction pathway 
PMK catalyzes the second step of the MVA pathway. It transfers the γ-phosphoryl group of 
ATP to the phosphoryl group of PMV, yielding (R)-5-diphosphomevalonate (DPM) (Figure 
2). Similar to other GHMP superfamily kinases, PMK contains three conserved sequence 
motifs (I-III) 1 (Figure 3). The most conserved motif II has a sequence of Pro-X-X-Gly-Leu-
X-Ser-Ser-Ala, which is folded into the phosphate binding loop or p-loop. 
 
 
Figure 2. The mevalonate pathway: The phosphorylation of mevalonate-5-phosphate 
(highlighted in dashed box) is catalysed by PMK.  
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The crystal structure of PMK from S. pneumoniae showed that a Mg2+ ion is coordinated to 
the γ-phosphoryl group of ATP and the phosphoryl group of the substrate, as well as to 
Asp297 and three structural water molecules (Figure 4A). A highly conserved residue, Lys9 
located in the motif I, forms strong ionic interactions with the PMV phosphoryl group and the 
γ-phosphoryl group of ATP, stabilizing the substrate and nucleotide along the reaction path. 
This is in line with previous studies on the effect of the mutation of Lys9 on the affinity for 
PMV. 40 Lys101, located at the end of the p-loop, is in close proximity to the β-, γ- bridging 
oxygen. Comparison of the ligand-bound and apo PMK structures disclosed the repositioning 
of this residue to stabilize the negative charge developed during phosphoryl transfer. 28 
Ser107, also located in the motif II p-loop, is H-bonded to the β-phosphate of ATP, although 
there have been no direct mutagenesis studies that address its role in substrate recognition or 
turnover. In addition, the backbone of Ala293 is H-bonded to the phosphoryl group of PMV. 
Mutation of Ala293 selectively increased the Michaelis constant for PMV (KM,PMV) 17,000-
fold and decreased the turnover number (kcat) considerably (64 fold), indicating that it plays a 
significant role in catalysis by stabilizing the phosphate group of PMK during the reaction. 40 
Ser213, located on an α-helix at the catalytic site, forms a H-bond with one of the coordinated 
water molecules, as well as the phosphoryl group of PMV, although mutation of this residue 
only modestly decreased the kcat.40  
The catalytically important residues may execute their functions via communication with 
distant residues. 41 MD simulation enables the entire protein structure including the distant 
residues as well as the active site residues to evolve with time in response to the mutations. In 
order to elucidate the role of these residues during the catalytic reaction and locate the 
starting structure of the reactant to be used in the subsequent diabatic potential energy surface 
scan, a 10-ns MD simulation was performed on the PMK in complex with ATP, the substrate 
and Mg2+ ion. 
Distinct from other GHMP kinases, PMK catalyzes the transfer of the γ-phosphate of ATP to 
another negatively charged phosphate in the substrate. In addition, Mg2+ is only coordinated 
to the γ-phosphoryl group of ATP in PMK, whereas it is coordinated to at least two 
phosphoryl groups of ATP in other GHMP kinases. 10 Prior to the MD simulations and 
potential energy surface scan, we searched and examined the structures of diverse kinases for 
which the phosphorylation mechanisms have been elucidated to decide the protonation state 
of the substrate. Human galactokinase, a member of GHMP family, follows a direct 
phosphorylation mechanism, where Arg228 was found to move close to, and stabilize, the 
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negative charge developed at the β-,γ- bridging oxygen atom of the ATP during bond 
cleavage (supporting information Figure S1). 10 The proton of C1 hydroxyl group of galactose 
transfers to the γ- phosphate oxygen atom of ATP and the phosphoryl transfer coincides with 
the proton migration from galactose. ErbB3 kinase also follows a direct phosphorylation 
mechanism where the substrate (tyrosine) acts as a proton donor, donating a proton onto the 
γ-phosphate during phosphorylation. 42 Ting Shi et al. disclosed a catalytic acid mechanism 
for CheA histidine kinase where the β-, γ- bridging oxygen of ATP forms a hydrogen-bond 
network with two water molecules, which participate in the protein relay from the catalytic 
acid Lys48 to the β-, γ- bridging oxygen of the ATP. 43 A catalytic base mechanism was 
suggested for cyclin-dependent protein kinases, where Asp127 acts as a catalytic base to 
abstract a proton from the substrate serine, which attacks the γ-phosphate of ATP. 44 Despite 
of the diversity of the reaction mechanisms of the kinases, proton transfer from the substrate 
hydroxyl group has been validated. Therefore, in our MD simulations, the oxygen (OP3) of 
PMV was protonated such that the substrate has a hydroxyl group to donate a proton (Figure 
3). 
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Figure 3. The highly conserved Motif II and p-loop in Streptococcus pneumoniae 
phosphomevalonate kinase (PDB ID: 3GON). 28 Motifs I-III are shown in purple, p-loop is 
shown in green, and the α-helix above the catalytic site is shown in red. 
As time evolved, we found the configuration of the active site of the PMK complex observed 
in the crystal structure of PMK was well maintained throughout the MD simulation. The 
Mg2+ is octahedrally coordinated to Asp297, the phosphoryl group of PMV, the γ-phosphoryl 
group of ATP, as well as three structural water molecules. Lys9 is located between PMV and 
ATP, stabilizing the γ-phosphoryl group of ATP and the phosphoryl group of PMV, which in 
turn forms a H-bond with the backbone of Ala293.  In the crystal structure of PMK, Ser213 
located on the α-helix at the catalytic site is positioned to form a H-bond with a coordinating 
water, as well as the PMV phosphate. Interestingly, with time evolution in the MD simulation, 
the hydroxyl group of the Ser213 further approached the substrate phosphate, forming a 
stronger H-bond with the substrate. As a result, the original H-bond interaction with the 
structural water observed in the crystal structure was lost (Figure 4).  
In a previous computational study on the mechanism of galactokinase, another GHMP kinase, 
the positively charged Arg228 functions to stabilize the negative charge developed at the β,γ-
bridging oxygen of the ATP during bond cleavage. 10 Two conserved catalytic residues 
(Ser141 and Ser142) in galactokinase stabilize ATP in the oxyanion hole. Although the 
coordination environment of the Mg2+ ion in the two GHMP kinases is different, we 
identified the corresponding functional residues in PMK by careful comparison of structures 
of galactokinase and PMK obtained from MD simulations. Analogous to Arg228 in 
galactokinase, Lys101 in PMK is H-bonded to the β-,γ- bridging oxygen of ATP and could 
stabilize the negative charge which develops during phosphoryl transfer. When comparing 
the sequences of GHMP kinases, we found Lys101 in S. pneumoniae PMK is located on a 
unique KKF insertion at the beginning of the p-loop (Figure S2). In the crystal structure of 
PMK, Ser106 on motif II points away from the catalytic site while Ser107 is H-bonded to the 
β-phosphoryl group of ATP. Interestingly, with time evolution in the MD simulation, the 
hydroxyl group of Ser106 moves towards the oxygen atom of the α-phosphoryl group of ATP 
to form a H-bond (Figure 4). Thus, Ser106, along with the adjacent serine Ser107, can be 
analogous to the two conserved serine residues on the p-loop of galactokinase, functioning to 
anchor the nucleotide in the catalytic oxyanion hole. 
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Figure 4. The catalytic centre of PMK. (A) The crystal structure of PMK: The Mg2+ ion is (in 
purple) in complex with ATP and PMV. (B) The simulated structure from 10 ns MD 
simulation. 
 
3.2 Effect of sequence alterations on Mg2+ coordination 
In order to understand the effect of alteration of key residues that may be involved in the 
reaction pathway of PMK, Lys9, Lys101 and Ala293 were altered and 10-15 ns MD 
simulations carried out. When the ammonium ion of the Lys 9 was replaced with the 
guanidinium group of arginine, a significant decrease of kcat was reported. 40 A similar effect 
was observed while the alanine at the position 293 was substituted by threonine. Therefore, 
we simulated the corresponding variants K9R and A293T variants. Lys9 was also replaced by 
a neutral residue methionine, which has a similar length to lysine but couldn’t establish 
electrostatic interactions with the phosphoryl groups of the substrate or ATP. The lysine at 
position101, which was suggested to stabilize the negative charge which develops during the 
breakage of the P-O bond between the β and γ-phosphoryal groups of ATP, was also mutated 
into arginine and methionine, respectively. 
In the MD simulation of K9R, the RMSD value of the protein backbone increased slightly as 
time elapsed and finally stabilized at ~1.0 Å from 4 ns onwards (Figure S3). This slight 
fluctuation indicates that there were no significant conformational changes in the protein over 
the time period studied. A representative structure of the last nanosecond (Figure 5) was 
compared to the wide-type complex structure. When the lysine residue at position 9 was 
changed to arginine, the coordination of Mg2+ was distorted. Two water molecules moved 
away resulting in an unstable conformation of the active site. 
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In the MD simulation of K9M, the RMSD value of the protein backbone slightly increased 
from 0.8 Å to 1.5 Å in the first 3 ns and then stabilized to approximately 1.2 Å, indicating 
that the system remained stable and had reached equilibrium. The positively charged Lys9 is 
believed to stabilize phosphate group of both ATP and PMV during the reaction. When Lys9 
was altered to the neutral amino acid methionine, one water molecule moved away from the 
active site yielding an unstable pentacoordinated Mg2+. 
Previous studies on various kinases that contain an invariant lysine residue in their catalytic 
domains showed that this residue is actively involved in phosphorylation but is not required 
for anchoring ATP. 45 GTMP kinases are different from classical kinases in that such a lysine 
is absent in the motif II p-loop, 10 except for PMK, which contains a lysine at the end of the 
p-loop. However, we have previously found that a positively charged residue (Arg228) in 
galactokinase can reorientate toward ATP to facilitate the phosphoryl transfer. 10 Similar to 
Arg228 in galactokinase, Lys101 functions to stabilize the negative charge developed at the 
β-, γ-bridging oxygen atom of ATP during phosphoryl transfer.  
The RMSD graph of the MD simulation of K101R fluctuated in the first 5 ns and became 
stabilized at approximately 1.2 Å, indicating that the system remained stable and had reached 
equilibrium after 5 ns. When lysine was altered to arginine in K101R, one of the coordinated 
water molecules moved far away from Mg2+ disrupting the coordination of the ion. This 
observation is in consistent with the functional role of conserved lysine of classical kinases in 
orienting and facilitating the phosphate transfer. 40 
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Figure 5. Close up view of the catalytic sites of WT PMK and the mutated kinase. Structures 
were obtained by 10-15ns MD simulations. 
 
The protein backbone in the MD simulation of K101M fluctuated majorly in the first 10 ns, 
which indicates that significant conformational changes occurred in the system with this 
alteration. The RMSD value slightly decreased after 10 ns and finally stabilized around ~1.2 
Å from 12 ns. Ser213 is pushed away from active site when Lys101 was replaced to 
methionine. This suggests Lys101 helps to grasp Ser213 around the substrate phosphoryl 
group to facilitate the proton transfer during phosphorylation. 
In the work of Andreassi, J. L et al. alteration of Ala293 on the steady-state kinetic 
parameters of the PMK-catalyzed reaction was profound affecting both KM,PMV and kcat, 40 
indicating this residue has significant influence on the binding affinity of the enzyme for the 
substrate as well as the catalytic efficiency of the enzyme. In the MD simulation of A293T, 
the protein backbone remained fairly stable during the 8 ns simulation fluctuating slightly by 
approximately 1.0 Å. The threonine at position 293 formed a H-bond with the catalytic 
residue Asp297, replacing the original H-bond network between Asp297 and three 
coordinating water molecules in the crystal structure (Figure S4), as a result, all the three 
coordinating water molecules moved away from the active site and the coordination of Mg2+ 
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was completely disrupted. This indicates Ala293 plays a significant role in the catalytic 
reaction by maintaining the space requested the coordinating water and therefore the 
octahedral coordination of the magnesium ion.  
 
3.3 Reaction pathway of PMK by QM/MM study  
In the MD simulation of WT PMK, we observed that Ser213 on the α-helix at the catalytic 
site is repositioned to further approach the substrate. We propose the resulting tight H-bond 
network would facilitate the proton transfer from the hydroxyl group of the substrate to the γ-
phosphoryl group of ATP. Therefore, this residue was included in the QM region, along with 
other previously identified catalytically important residues Ala293, Lys9 and Lys101. The 
substrate PMV, Asp297, and three coordinated water molecules that are coordinated to the 
Mg ion were also included in the QM region (Figure 1). In the QM/MM calculations on the 
phosphorylation reaction of protein kinase A (PKA), the triphosphate arm of ATP and the 
entire ATP molecule were included in the QM region. 46 Both of the results were 
approximately consistent with the experimental estimation, indicating that the triphosphate 
arm of ATP in QM should be sufficient and efficient in the study of catalytic mechanism. 
Thus it is not always necessary to have a large QM region to minimize the difference between 
the theoretical and the experimental energies due to the additional approximations for a large 
QM/MM boundary. Therefore, here we only kept the triphosphate arm of ATP in the QM 
region. 
Electronic embedding incorporates the partial charges of the MM region into the quantum 
mechanical Hamiltonian. This technique provides a better description of the electrostatic 
interaction between the QM and MM regions than the mechanical embedding method and 
allows the QM wave function to be polarized by the MM environment. 47 
Ten representative structures were selected from the wild-type MD simulation. All of these 
structures were optimized by QM/MM to decide the suitable starting structure for the 
subsequent potential energy scan (Figure S5). Important interatomic distances of these 
structures are listed in Table S2. Cluster7 was selected for a further potential energy surface 
scan. The adiabatic mapping approach was used to delineate the reaction path and locate 
stationary points such as transition state and product. 48 A two-dimensional potential energy 
surface (PES) scan was calculated to understand the conformational change along reaction 
path by defining the distances of d1= d(Pγ-Oβ3) and d2=d (Pγ-OP3) as the reaction coordinates.  
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The kcat value is 3.4 s-1 at 310 K for PMK from S. pneumoniae, 49 corresponding to an 
activation energy of 17.34 kcal/mol. By the QM/MM method a transition state was located 
with d1=2.27 Å and d2=2.08 Å and was validated by a unique imaginary frequency of -140.62 
cm-1 that corresponds to the γ-phosphate transfer to PMV (Figure 6). The transition state was 
optimized employing mechanical embedding and associated with a potential energy barrier of 
15.87 kcal/mol (Figure 7), which is in good agreement with the kinetic data.  
 
 
Figure 6. The QM/MM optimized structures of the reactant, transition state (where d1 =2.27 
Å, d2= 2.08 Å) and product. 
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Figure 7. The potential energy surface scan, with the distance d1= d(Pγ-Oβ3) and d2= d(Pγ-OP3) 
as the reaction coordinates, yields an activation barrier of 15.87 kcal/mol 
Pauling’s formula 50: D(n) = D(l) − 0.6 logn was used to estimate associative or dissociative 
character of the transition state. Here, D(l) is 1.73 Å for the P−O bond and D(n) is the 
average of rO1−Pγ and rPγ−Oβ3 at the transition state. The fractional bond number (n) is 0.18, 
which gives a dissociative character of 82%. According to the transition state structure 
disclosed by QM/MM calculations, a possible mechanism for PMK was proposed (Figure 8). 
While the substrate gradually approaches ATP, the hydroxyl hydrogen atom of the phosphate 
in the substrate (H-OP3) migrates to γ-phosphate oxygen atom (Oγ3) of ATP. The backbone 
amino group of Ala293 is hydrogen-bonded with phosphoryl oxygen (OP2) atom of PMV, 
facilitating the proton transfer from the substrate to the γ-phosphate of ATP. Lys9 is proposed 
to stabilize both the transition state and product conformation. Lys101 is suggested to help 
neutralizing the negative charge developed at the β-,γ- bridging oxygen of ATP during 
phosphorylation.  
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Figure 8. Proposed phosphorylation mechanism of PMK. 
 
 
 
4. Conclusions  
 
PMK, a member of GHMP family was studied in detail using MD simulations and hybrid 
QM/MM calculations. Important catalytic residues were identified, including a highly 
conserved residue (Lys9) that stabilizes the phosphoryl groups of the substrate and ATP and 
Ala293 that tethers the substrate by a hydrogen bond with the phosphoryl group. These 
observations are all in agreement with enzymological and mutagenesis studies on this kinase. 
We found that the highly conserved Lys101 near the ATP binding site stabilizes the negative 
charge that develops at the β-, γ-bridging oxygen atom of ATP during the cleavage of the P-O 
bond. In addition, a conserved serine residue on the p-loop, Ser106, reorientates to anchor the 
nucleotide in the catalytic site. Moreover, Ser213 on the α-helix at the catalytic site further 
approaches the substrate to form a tight H-bond network with the hydroxyl oxygen of the 
protonated phosphoryl group, facilitating the proton transfer during phosphorylation. 
Based on the protein structure and current results obtained in this research, the mechanism of 
PMK is believed to follow a direct attack pathway and the phosphoryl transfer occurs through 
a dissociative-dominated mechanism. A potential transition state structure was located, which 
was validated by a unique imaginary frequency. Thus despite of the different configuration of 
the active sites of GHMP kinases and divergent substrates, it appears (that) many, perhaps all, 
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GHMP kinases follow a direct phosphorylation mechanism. This research discloses the 
reaction mechanism of PMK, a representative kinase in the MVA pathway. It has potential 
impact in both drug discovery and biotechnology. In particular these studies have identified 
catalytically important residues which could be targeted by MVK inhibitors in the search for 
novel antibiotics.  They may also provide guidance for the engineering attempts to alter or 
broaden the substrate specificity of MVK. 
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